Track topics on Twitter Track topics that are important to you
STOCKHOLM, Sweden, June 4, 2015 (GLOBE NEWSWIRE) -- Neonode Inc. (Nasdaq:NEON), the optical touch technology company, today announces that it has signed a development and license agreement with Samsung Electronics Co., Ltd. to incorporate zForce CORE technology into its printer applications.
"We believe that a good user interface is a key enabler of all successful products going forward. That's why we launched the world's first Android based printing ecosystem, 'Smart UX Center.' We continue to put a massive effort into customer-driven innovation and signing a license agreement with Neonode is one of the example of it. It will give us access to a touch technology that combines the best user experience with a leading cost and quality assurance for Samsung's successful range of printers," said Kasey Kim, the head of R&D Planning Group of Printing Solutions Business at Samsung Electronics.
"We are proud to announce the signing of this agreement with Samsung, a key player not only in the printer market but also in consumer electronics globally. This event further solidifies our position as the ultimate touch technology in the printer segment and further proves the strength and usefulness of Neonode's technology. We are looking forward to a long and successful relationship with Samsung," said Thomas Eriksson, CEO at Neonode.
Neonode Inc. (Nasdaq:NEON) develops and licenses the next generation of MultiSensing® touch technologies, allowing companies to differentiate themselves by making high performing touch and proximity sensing solutions at a competitive cost. Neonode is at the forefront of providing unparalleled user experiences that offer significant advantages for OEM's. This includes state-of-the-art technology features such as low latency pen or brush sensing with high speed scanning, proximity-, pressure-, and depth-sensing capabilities and object-size measuring on any surface.
Neonode's patented MultiSensing touch technology is developed for a wide range of devices like wearables, notebooks, all in one computers, monitors, mobile phones, tablets and e-readers, toys and gaming consoles, printers and office equipment and automotive systems. NEONODE, the NEONODE Logo, ZFORCE and MULTISENSING are trademarks of Neonode Inc. registered in the United States and other countries. ZFORCE CORE, ZFORCE PLUS and ZFORCE DRIVE are trademarks of Neonode Inc. All other trademarks are the property of their respective owners. For more information please visit www.neonode.com.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These include, but are not limited to, statements relating to expectations, future performance or future events, and product cost, performance, and functionality matters. These statements are based on current assumptions, expectations and information available to Neonode management and involve a number of known and unknown risks, uncertainties and other factors that may cause Neonode's actual results, levels of activity, performance or achievements to be materially different from any expressed or implied by these forward-looking statements.
These risks, uncertainties, and factors are discussed under "Risk Factors" and elsewhere in Neonode's public filings with the U.S. Securities and Exchange Commission from time to time, including Neonode's annual report on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K. You are advised to carefully consider these various risks, uncertainties and other factors. Although Neonode management believes that the forward-looking statements contained in this press release are reasonable, it can give no assurance that its expectations will be fulfilled. Forward-looking statements are made as of today's date, and Neonode undertakes no duty to update or revise them.
© Copyright 2015 Neonode Inc. All rights reserved. Neonode is a registered trademark of Neonode Inc.
CONTACT: Sales Printer Solutions: Bengt Edlund +46-708-722-800 E-Mail: email@example.com Investor Relations: David Brunton Email: firstname.lastname@example.orgNEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...